Concepedia

Publication | Open Access

Phase Ib Study of Enzalutamide with or Without Sorafenib in Patients with Advanced Hepatocellular Carcinoma

DOIFull Paper Access

15

Citations

21

References

2020

Year

James J. Harding, Robin Kate Kelley, Benjamin Tan, Marinela Capanu, Richard Kinh Gian, Jinru Shia, Joanne F. Chou, Christine S. Ferrer, Chayma Boussayoud, Kerri Muenkel,
The Oncologist

Abstract

Enzalutamide is ineffective in HCC; further development is not supported by this study.

References

YearCitations

Page 1